You are viewing the site in preview mode
Skip to main content
| |
Adenosine
|
Dipyridamole
|
|---|
|
Dosage
|
Intravenous (i.v.) – 140 μg/kg/min
|
Intravenous – 0,56–0,84 mg/kg
|
|
Duration of action
|
30 sec
|
30 min
|
|
Time to max. effect
|
30–55 sec
|
6–16 min
|
|
Advantage
|
Short action, short-lasting adverse effects
|
prolonged action allow to assess CFR and wall motion abnormalities during single examination
|
|
Disadvantage
|
AV conduction delay (including complete heart block), Hyperventilation, hypotension, flushing, headache,
|
possibility of antidote-resistance prolonged ischemia, hypotension, flushing, headache, hyperventilation,
|